Merit Medical's Forward P/E of 19.05 Beats Straumann's 29.03
Merit Medical holds a Zacks Rank of #2 (Buy) compared with Straumann Holding’s #3 (Hold), reflecting an improving earnings revision trend. Merit Medical’s forward P/E is 19.05 versus Straumann’s 29.03, its PEG is 2.00 vs 2.47, and its P/B is 2.89 versus 7.66, earning a Value grade of B over C.
1. Zacks Rank Comparison
Merit Medical has achieved a Zacks Rank of #2 (Buy) due to recent positive earnings estimate revisions, while Straumann Holding sits at a #3 (Hold). This rank differential highlights a stronger near‐term earnings outlook for Merit Medical relative to its peer.
2. Valuation Metrics Analysis
Merit Medical trades at a forward P/E of 19.05 compared with Straumann’s 29.03, and its PEG ratio of 2.00 undercuts Straumann’s 2.47. Additionally, Merit Medical’s P/B ratio of 2.89 versus 7.66 and a Value grade of B versus C underscore its relative undervaluation based on key fundamentals.